Allworth Financial LP Sells 118 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Allworth Financial LP decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 0.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,009 shares of the healthcare conglomerate’s stock after selling 118 shares during the period. Allworth Financial LP’s holdings in UnitedHealth Group were worth $13,873,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. NorthCrest Asset Manangement LLC grew its holdings in UnitedHealth Group by 9.5% during the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock valued at $264,000 after purchasing an additional 45 shares during the period. Cullinan Associates Inc. grew its holdings in UnitedHealth Group by 2.1% during the second quarter. Cullinan Associates Inc. now owns 27,068 shares of the healthcare conglomerate’s stock valued at $13,903,000 after purchasing an additional 555 shares during the period. 626 Financial LLC grew its holdings in UnitedHealth Group by 1.5% during the second quarter. 626 Financial LLC now owns 2,387 shares of the healthcare conglomerate’s stock valued at $1,224,000 after purchasing an additional 35 shares during the period. EverSource Wealth Advisors LLC grew its holdings in UnitedHealth Group by 67.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,557 shares of the healthcare conglomerate’s stock valued at $1,303,000 after purchasing an additional 1,032 shares during the period. Finally, TPG Financial Advisors LLC grew its holdings in UnitedHealth Group by 8.6% during the second quarter. TPG Financial Advisors LLC now owns 2,423 shares of the healthcare conglomerate’s stock valued at $1,245,000 after purchasing an additional 192 shares during the period. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Stock Up 1.1 %

Shares of NYSE:UNH opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a market cap of $484.02 billion, a PE ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The stock’s 50-day moving average is $530.11 and its 200 day moving average is $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter in the previous year, the business earned $4.70 EPS. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s payout ratio is 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the sale, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. SVB Leerink raised their price target on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. UBS Group raised their price target on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a report on Thursday, July 21st. Morgan Stanley raised their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Finally, Argus lifted their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research note on Monday, July 25th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.